Taisho Pharmaceutical Co., Ltd.
46
4
4
39
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.2%
1 terminated/withdrawn out of 46 trials
97.5%
+11.0% vs industry average
20%
9 trials in Phase 3/4
5%
2 of 39 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (46)
A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis
Role: lead
A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
Role: lead
A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
Role: lead
A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
Role: lead
A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
Role: lead
A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
Role: lead
A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects
Role: lead
A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
Role: lead
Antidepressant Effects of TS-161 in Treatment-Resistant Depression
Role: collaborator
A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects
Role: lead
An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis
Role: lead
A Drug-drug Interaction Study With TS-172 in Healthy Adult Male Subjects
Role: lead
Long-Term Study of TS-142 in Patients with Insomnia
Role: lead
A Phase I Study of TS-142 in Healthy Participants (Single Doses)
Role: lead
A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects
Role: lead
A Food Effect Study of TS-142 in Healthy Subjects
Role: lead
A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)
Role: lead
A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.
Role: lead
A Pharmacokinetic Study of TS-142 in Patients with Hepatic Impairment
Role: lead
Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3
Role: lead